Achieve Life Sciences

(NASDAQ) ACHV

Current Price$5.58

Market Cap$574.89M

Since IPO (2017)-99%

5 Year-33%

1 Year+72%

1 Month+6%

Achieve Life Sciences Financials at a Glance

Market Cap

$574.89M

Revenue (TTM)

$0.00

Net Income (TTM)

-$51.99M

EPS (TTM)

-$1.12

P/E Ratio

-5.02

Dividend

$0.00

Beta (Volatility)

1.03 (Average)

Dividend

$0.00

Beta (Volatility)

1.03 (Average)

Price

$5.58

Volume

75,769

Open

$5.64

Price

$5.58

Volume

75,769

Open

$5.64

Previous Close

$5.58

Daily Range

$5.32 - $5.75

52-Week Range

$2.00 - $6.16

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

1.03 (Average)

Price

$5.58

Volume

75,769

Open

$5.64

Previous Close

$5.58

Daily Range

$5.32 - $5.75

52-Week Range

$2.00 - $6.16

Estimated Earnings Date

Aug 6, 2026

ACHV News

Achieve (ACHV) Q2 Net Loss Hits $12.7M

Motley Fool Markets TeamAug 7, 2025

ACHV: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Achieve Life Sciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Richard Alistair Balfour Stewart

Website

www.achievelifesciences.com

Headquarters

Vancouver, BC V6E 4H1, CA

ACHV Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-496%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-19.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$574.89M

Shares Outstanding

102.66M

Volume

75.77K

Avg. Volume

1.42M

Financials (TTM)

Gross Profit

-$228.00K

Operating Income

-$54.88M

EBITDA

-$53.60M

Operating Cash Flow

-$49.47M

Capital Expenditure

-$3.00K

Free Cash Flow

-$49.47M

Cash & ST Invst.

$36.40M

Total Debt

$14.96M

Achieve Life Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$57.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$574.89M

N/A

Market Cap/Employee

$23.00M

N/A

Employees

N/A

Net Income

-$10.17M

+20.7%

EBITDA

-$9.84M

+21.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$29.27M

+25.9%

Total Debt

$14.95M

+50.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$9.32M

+7.0%

Short Term Debt

$5.63M

+350.0%

Return on Assets

-1.57%

N/A

Return on Invested Capital

-2.47%

N/A

Free Cash Flow

-$6.93M

+37.5%

Operating Cash Flow

-$6.93M

+37.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ALLOAllogene Therapeutics, Inc.

ALLOAllogene Therapeutics, Inc.$1.94+2.11%

VNDAVanda Pharmaceuticals Inc.

VNDAVanda Pharmaceuticals Inc.$5.88+0.17%

AVIRAtea Pharmaceuticals, Inc.

AVIRAtea Pharmaceuticals, Inc.$4.35-3.12%

TRDAEntrada Therapeutics, Inc.

TRDAEntrada Therapeutics, Inc.$6.58+1.78%

VYGRVoyager Therapeutics, Inc.

VYGRVoyager Therapeutics, Inc.$3.63+3.71%

SGMTSagimet Biosciences Inc.

SGMTSagimet Biosciences Inc.$6.47-0.15%

ARCTArcturus Therapeutics Holdings Inc.

ARCTArcturus Therapeutics Holdings Inc.$7.33+5.16%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.89+0.02%

NOKNokia

NOKNokia$14.82+0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$84.59+0.09%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$36.31-0.09%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$744.00+0.03%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.85+0.01%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$192.80+0.20%

Questions About ACHV

What is the current price of Achieve Life Sciences?

Achieve Life Sciences is trading at $5.58 per share.

What is the 52-week range for Achieve Life Sciences?

Over the past 52 weeks, Achieve Life Sciences has traded between $2.00 and $6.16.

How much debt does Achieve Life Sciences have?

As of the most recent reporting period, Achieve Life Sciences reported total debt of $14.95M.

How much cash does Achieve Life Sciences have on hand?

Achieve Life Sciences reported $28.08M in cash and cash equivalents in its most recent financial results.

What is Achieve Life Sciences’s dividend yield?

Achieve Life Sciences does not currently have a dividend yield.

Achieve Life Sciences

Achieve Life Sciences Financials at a Glance

ACHV News

Achieve (ACHV) Q2 Net Loss Hits $12.7M

ACHV: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Achieve Life Sciences

ACHV Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Achieve Life Sciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ACHV

What is the current price of Achieve Life Sciences?

What is the 52-week range for Achieve Life Sciences?

How much debt does Achieve Life Sciences have?

How much cash does Achieve Life Sciences have on hand?

What is Achieve Life Sciences’s dividend yield?

Premium Investing Services